Why Partner with BIOVIA
-
Upload
greg-nutkins -
Category
Software
-
view
94 -
download
1
description
Transcript of Why Partner with BIOVIA
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
3DS.
CO
M ©
Das
saul
t Sys
tèm
es |
Conf
iden
tial I
nfor
mat
ion
| 8/1
3/20
14 |
ref.:
3DS
_Doc
umen
t_20
143D
S.C
OM
© D
assa
ult S
ystè
mes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
Increase your revenue and profits, increase the technical expertise of your staff, expand your horizons, delight your customer
Why Partner with BIOVIA
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
BIOVIA – Use Our Expertise and ReferencesOver 2,000 customers
• 10 of the top 10 pharmaceutical
• 20 of the top 25 biotech
• 7 of the top 10 chemical
• 4 of the top 5 consumer packaged goods
• 5 of the top 10 oil & gas
• 5 of the top 5 aerospace
• Government and academic institutions
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
BIOVIA – Offer Your Customer a Variety of Solutions• Chemical and Biological Modeling and Simulation
• Material Modeling and Simulation
• Systems Biology and Integrative Therapeutics
• Open Collaborative Discovery
• Enterprise Laboratory Management
• Process Manufacturing Intelligence
• Enterprise Quality Management
• Scientific Pipelining
• Bioactivity and Chemical Sourcing Content
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
Gartner‘s View – Listen to the Industry Analysts
• “…Dassault Systèmes now has the most extensive portfolio of life sciences capabilities serving the R&D and product commercialization needs of both medical device and pharmaceutical manufacturers.”
• “Biovia should have a strong impact in the R&D space for pharmaceuticals, biotechnology firms and academic research institutions.”
“Dassault Systèmes’ BIOVIA is Poised to Capture PLM Life Science Market”Gartner Analysts: Michael Shanler, Marc Halpern Published May 27, 2014
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
Why Partner with BIOVIA – Unique Benefits• We want Long term partners
• We have Competitive products with customer demand
• We are Experienced in marketing and lead generation
• We offer Negotiable geography with growth
• You can Start with one product set and grow to more
• We offer A relationship built on the need to grow your business
• We offer Pricing and margin flexibility
• We are Experienced in partner relations and growing partners
• We have A long term business vision
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
Local and Global Support• Reference customers across the globe
• Customers using one, two or all applications
• Small local customers to global accounts
• Partner Portal with; references, case studies, pricing, marketing etc
• Full training; product, sales, implementation and services
• Quick ordering and delivery
• Sales databases for different sectors
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014
We are looking for• Companies within EMEA with• Life Science Research and Development experience• Systems Integrators, Consultants, Lab Equipment Providers, Software Solution Providers,
Independent Software Vendors and others
• Preferably with experience of;• Lab Information Systems (ELN/LIMS/LES) or similar• Chemical Inventory Management (CISPro or similar)• Modelling and Simulation Software (molecular, FEA, fluid flow or similar)• Scientific Pipelining (Pipeline Pilot or similar)
• If you feel you would like to know more – contact me at [email protected]
3DS.
CO
M/B
IOVI
A ©
Dass
ault
Syst
èmes
| Co
nfid
entia
l Inf
orm
atio
n | 8
/13/
2014
| re
f.: 3
DS_D
ocum
ent_
2014